Shares of Moderna rose 5.59% to $161.05 at 14:23 EST on Monday, following yesterday’s downward trend. The Nasdaq Stock Market is jumping 0.28% to $12,499.40, after two consecutive sessions in a row of gains, on what up to now seems, a somewhat positive trend exchanging session today.
Moderna’s last close was $152.52, 10.84% under its 52-week high of $178.50.
News about Moderna today
Early bet on Moderna sees top european fund gain 65% this year. According to today’s article on Bloomberg Quint, “A Baillie Gifford & Co. health care fund run by an all-female team has surged past peers to a 65% gain this year, largely thanks to a far-sighted bet on medical stock Moderna Inc.”
Moderna shares rally as Canada doubles vaccine order. According to today’s article on MarketWatch, “Shares of Moderna Inc. rallied 1.3% in morning trading Monday, after the biotechnology company said the Canadian government has doubled its order commitment for has gained 7.8%.”
Moderna’s sales growth is 1428.1% for the ongoing quarter and 13065.3% for the next. The company’s growth estimates for the present quarter is a negative 48.6% and positive 565.7% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s Stock Top and Bottom Yearly Value
Moderna’s stock is valued at $161.05 at 14:23 EST, under its 52-week high of $178.50 and way above its 52-week low of $17.68.
Moderna’s Moving Average
Moderna’s worth is way above its 50-day moving average of $91.57 and way higher than its 200-day moving average of $73.81.